These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 17015477)

  • 21. Secreted frizzled-related protein 4 inhibits proliferation and metastatic potential in prostate cancer.
    Horvath LG; Lelliott JE; Kench JG; Lee CS; Williams ED; Saunders DN; Grygiel JJ; Sutherland RL; Henshall SM
    Prostate; 2007 Jul; 67(10):1081-90. PubMed ID: 17476687
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pioglitazone, a synthetic ligand for PPARgamma, induces apoptosis in RB-deficient human colorectal cancer cells.
    Lee CJ; Han JS; Seo CY; Park TH; Kwon HC; Jeong JS; Kim IH; Yun J; Bae YS; Kwak JY; Park JI
    Apoptosis; 2006 Mar; 11(3):401-11. PubMed ID: 16520894
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Methyl 2-cyano-3,11-dioxo-18 beta-olean-1,12-dien-30-oate is a peroxisome proliferator-activated receptor-gamma agonist that induces receptor-independent apoptosis in LNCaP prostate cancer cells.
    Papineni S; Chintharlapalli S; Safe S
    Mol Pharmacol; 2008 Feb; 73(2):553-65. PubMed ID: 17989348
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Repression of NHE1 expression by PPARgamma activation is a potential new approach for specific inhibition of the growth of tumor cells in vitro and in vivo.
    Kumar AP; Quake AL; Chang MK; Zhou T; Lim KS; Singh R; Hewitt RE; Salto-Tellez M; Pervaiz S; Clément MV
    Cancer Res; 2009 Nov; 69(22):8636-44. PubMed ID: 19887620
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bacillus Calmette-Guérin induces the expression of peroxisome proliferator-activated receptor gamma in bladder cancer cells.
    Lodillinsky C; Umerez MS; Jasnis MA; Casabé A; Sandes E; Eiján AM
    Int J Mol Med; 2006 Feb; 17(2):269-73. PubMed ID: 16391825
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 15-Lipoxygenase-2 gene regulation by its product 15-(S)-hydroxyeicosatetraenoic acid through a negative feedback mechanism that involves peroxisome proliferator-activated receptor gamma.
    Subbarayan V; Krieg P; Hsi LC; Kim J; Yang P; Sabichi AL; Llansa N; Mendoza G; Logothetis CJ; Newman RA; Lippman SM; Menter DG
    Oncogene; 2006 Sep; 25(44):6015-25. PubMed ID: 16682954
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Valproic acid inhibits invasiveness in bladder cancer but not in prostate cancer cells.
    Chen CL; Sung J; Cohen M; Chowdhury WH; Sachs MD; Li Y; Lakshmanan Y; Yung BY; Lupold SE; Rodriguez R
    J Pharmacol Exp Ther; 2006 Nov; 319(2):533-42. PubMed ID: 16868035
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of cell proliferation by potential peroxisome proliferator-activated receptor (PPAR) gamma agonists and antagonists.
    Lea MA; Sura M; Desbordes C
    Anticancer Res; 2004; 24(5A):2765-71. PubMed ID: 15517883
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Peroxisome proliferator-activated receptor-gamma ligand reduced tumor necrosis factor-alpha-induced interleukin-8 production and growth in endometriotic stromal cells.
    Ohama Y; Harada T; Iwabe T; Taniguchi F; Takenaka Y; Terakawa N
    Fertil Steril; 2008 Feb; 89(2):311-7. PubMed ID: 17555752
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gamma tocopherol upregulates the expression of 15-S-HETE and induces growth arrest through a PPAR gamma-dependent mechanism in PC-3 human prostate cancer cells.
    Campbell SE; Musich PR; Whaley SG; Stimmel JB; Leesnitzer LM; Dessus-Babus S; Duffourc M; Stone W; Newman RA; Yang P; Krishnan K
    Nutr Cancer; 2009; 61(5):649-62. PubMed ID: 19838939
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Low expression of ORF4, a dominant negative variant of peroxisome proliferator-activated receptor gamma, in colorectal adenocarcinoma.
    Bouancheau D; Jarry A; Mottier S; Toquet C; Masson D; Mosnier JF; Laboisse CL; Denis MG
    Oncol Rep; 2007 Aug; 18(2):489-95. PubMed ID: 17611675
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Overexpression of Jab1 in hepatocellular carcinoma and its inhibition by peroxisome proliferator-activated receptor{gamma} ligands in vitro and in vivo.
    Hsu MC; Huang CC; Chang HC; Hu TH; Hung WC
    Clin Cancer Res; 2008 Jul; 14(13):4045-52. PubMed ID: 18593980
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Peroxisome proliferator-activated receptor gamma in human prostate carcinoma.
    Nakamura Y; Suzuki T; Sugawara A; Arai Y; Sasano H
    Pathol Int; 2009 May; 59(5):288-93. PubMed ID: 19432669
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of peroxisome proliferator-activated receptor activation on gonadotropin transcription and cell mitosis induced by bone morphogenetic proteins in mouse gonadotrope LbetaT2 cells.
    Takeda M; Otsuka F; Otani H; Inagaki K; Miyoshi T; Suzuki J; Mimura Y; Ogura T; Makino H
    J Endocrinol; 2007 Jul; 194(1):87-99. PubMed ID: 17592024
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Valproic acid induces neuroendocrine differentiation and UGT2B7 up-regulation in human prostate carcinoma cell line.
    Valentini A; Biancolella M; Amati F; Gravina P; Miano R; Chillemi G; Farcomeni A; Bueno S; Vespasiani G; Desideri A; Federici G; Novelli G; Bernardini S
    Drug Metab Dispos; 2007 Jun; 35(6):968-72. PubMed ID: 17371798
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antitumor activity of the histone deacetylase inhibitor MS-275 in prostate cancer models.
    Qian DZ; Wei YF; Wang X; Kato Y; Cheng L; Pili R
    Prostate; 2007 Aug; 67(11):1182-93. PubMed ID: 17520666
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Peroxisome proliferator-activated receptor alpha and gamma ligands inhibit the growth of human ovarian cancer.
    Shigeto T; Yokoyama Y; Xin B; Mizunuma H
    Oncol Rep; 2007 Oct; 18(4):833-40. PubMed ID: 17786343
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of pioglitazone, a peroxisome proliferator-activated receptor gamma agonist, on ischemia-reperfusion injury in rats.
    Cao Z; Ye P; Long C; Chen K; Li X; Wang H
    Pharmacology; 2007; 79(3):184-92. PubMed ID: 17356310
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Peroxisome proliferator-activated receptor gamma inhibits follicular and anaplastic thyroid carcinoma cells growth by upregulating p21Cip1/WAF1 gene in a Sp1-dependent manner.
    Bonofiglio D; Qi H; Gabriele S; Catalano S; Aquila S; Belmonte M; Andò S
    Endocr Relat Cancer; 2008 Jun; 15(2):545-57. PubMed ID: 18509005
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vivo imaging of retinoic acid receptor beta2 transcriptional activation by the histone deacetylase inhibitor MS-275 in retinoid-resistant prostate cancer cells.
    Qian DZ; Ren M; Wei Y; Wang X; van de Geijn F; Rasmussen C; Nakanishi O; Sacchi N; Pili R
    Prostate; 2005 Jun; 64(1):20-8. PubMed ID: 15651062
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.